logo-loader
NASDAQ:ABVX EPA:ABVX

Abivax SA

Receive alerts
Market:
NASDAQ
Price
82.93 USD
Day Change
-1.07%
Market Cap:
$7.27 b
52 weeks high
148.53
52 weeks low
69.81

In brief

Abivax is a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases.

The company believes that harnessing the body’s natural regulatory mechanisms through enhanced expression of microRNA-124 can transform the way inflammatory diseases are treated.